Skip to content

Epidemiology and Treatment of Gastric Cancer

Epidemiology and Treatment of Gastric Cancer in the Federal State of Brandenburg From 2000 to 2020. An Analysis Using Data From the Clinical Cancer Registry for Brandenburg and Berlin.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07213115
Enrollment
8582
Registered
2025-10-08
Start date
2000-01-01
Completion date
2020-12-31
Last updated
2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric (Stomach) Cancer, Sex Difference

Keywords

Gastric Cancer, sex difference, registry data, epidemiology, treatment

Brief summary

According to recent statistics, the incidence and mortality from gastric cancer are both worldwide in fifth place in terms of ranking. Gastric cancer is more common in males than in females. This difference in the incidence between males and females is likely due to the difference in exposure to some risk factors like Helicobacter pylori infection, family history of gastric cancer, dietary habits, smoking and alcohol. However these factors do not completely explain the different characteristics of gastric cancer between the sexes. Some studies have concluded that exposure to estrogen could reduce the risk of gastric cancer. There is a lack of current population based and real world data on sex and age differences in gastric cancer care. Analyses of sex differences are primarily originate from Asia or focusing on older cohorts. In the Netherlands, Kalff et al. conducted a study with patients with gastric adenocarcinoma (n=2 072) registered in the Dutch Upper GI Cancer Audit between 2011 and 2016. In this study, patients without metastatic gastric cancer and with an elective surgery were included. To close this sex and age data gap for patients including those with UICC IV stage and without surgery, the aim of our study was to analyze the sex and age differences in clinicopathological features and staging in gastric adenocarcinoma with cancer registry data from the Federal State of Brandenburg from 2000 to 2020.

Interventions

Sponsors

Margarete-Ammon-Stiftung
CollaboratorUNKNOWN
Medizinische Hochschule Brandenburg Theodor Fontane
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* gastric adenocarcinomas (ICD-10-GM: C16.0 -C16.9)

Exclusion criteria

* missing age or sex

Design outcomes

Primary

MeasureTime frameDescription
Overall survival5 year, 10 yearSurvival time after date of cancer diagnosis

Other

MeasureTime frameDescription
sex differences5 year, 10 yearSex differences in epidemiology, Clinicopathological Characteristics, treatment, survival

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026